Comparative Effectiveness of Oral Drug Therapies for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Systematic Review and Network Meta-Analysis-Reference-Cited by-同舟云学术

Comparative Effectiveness of Oral Drug Therapies for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Systematic Review and Network Meta-Analysis

Published:2014-09-12 Issue:9 Volume:9 Page:e107593
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wang Xinghuan,Wang Xiao,Li Sheng,Meng Zhe,Liu Tao,Zhang Xinhua

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference99 articles.

1. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS;CC Sexton;BJU Int,2009

2. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms;MJ Barry;J Urol,2013

3. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey;V Kupelian;J Urol,2013

4. Benign prostatic hyperplasia: an overview;CG Roehrborn;Rev Urol,2005

5. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association;MJ Barry;J Urol,1992

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis;Scientific Reports;2024-05-15

2. Isoform‐independent promotion of contractility and proliferation, and suppression of survival by with no lysine/K kinases in prostate stromal cells;The FASEB Journal;2024-04-09

3. Konservative und medikamentöse Therapie des benignen Prostatasyndroms;Die Urologie;2023-10

4. A Review of Combined Phosphodiesterase-5-Inhibitors and α-Blockers versus Phosphodiesterase-5-Inhibitors Alone for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia;Arab Journal of Urology;2023-06-13

5. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14